Tag Archives: more

ACC: Amarin rolls out more Vascepa heart benefits data to back label expansion

Amarin has rolled out new Vascepa data that could change the way doctors prevent heart disease. Monday, the company trumpeted more data showing its fish oil-derived Vascepa could significantly cut heart risks, and the drugmaker plans to add the benefits to the product’s label. Investigators of the REDUCE-IT trial previously found Vascepa could slash the risk of… Read More »